| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
41,220 |
39,318 |
$2.98M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
9,850 |
9,442 |
$2.88M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
49,221 |
47,150 |
$2.05M |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
7,879 |
7,539 |
$823K |
| 80053 |
Comprehensive metabolic panel |
63,066 |
53,717 |
$714K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
76,227 |
65,095 |
$699K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
19,899 |
19,117 |
$675K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
8,999 |
5,028 |
$585K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
21,826 |
13,291 |
$504K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
3,227 |
3,116 |
$369K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
5,962 |
5,692 |
$333K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
6,296 |
6,071 |
$296K |
| 87631 |
|
4,038 |
3,872 |
$245K |
| 71046 |
Radiologic examination, chest; 2 views |
19,062 |
18,305 |
$209K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
8,802 |
8,056 |
$206K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,999 |
1,896 |
$196K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
232 |
225 |
$168K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
12,546 |
11,904 |
$167K |
| 84703 |
|
25,607 |
24,449 |
$163K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
8,828 |
4,627 |
$157K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,681 |
3,513 |
$157K |
| 87070 |
|
10,404 |
9,779 |
$111K |
| 84484 |
|
9,968 |
9,217 |
$106K |
| 81003 |
|
34,534 |
32,452 |
$104K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
5,384 |
4,868 |
$103K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
601 |
571 |
$101K |
| 86780 |
|
5,767 |
5,222 |
$100K |
| 84466 |
|
6,675 |
5,896 |
$99K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
7,571 |
7,073 |
$86K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,362 |
1,460 |
$67K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,429 |
1,379 |
$66K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
3,650 |
3,359 |
$62K |
| 82728 |
|
6,878 |
6,078 |
$60K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
2,168 |
2,003 |
$58K |
| 82607 |
|
3,891 |
3,491 |
$58K |
| 83690 |
|
7,600 |
7,248 |
$53K |
| 80061 |
Lipid panel |
2,912 |
2,806 |
$53K |
| 82746 |
|
3,867 |
3,467 |
$44K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,159 |
2,044 |
$40K |
| 83540 |
|
6,710 |
5,928 |
$39K |
| 83735 |
|
5,417 |
4,945 |
$39K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
8,353 |
6,369 |
$38K |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
66 |
38 |
$29K |
| 71045 |
Radiologic examination, chest; single view |
5,168 |
4,902 |
$29K |
| 83615 |
|
5,409 |
4,534 |
$28K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,593 |
2,405 |
$28K |
| 95816 |
|
624 |
604 |
$27K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
960 |
906 |
$26K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
239 |
232 |
$26K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
120 |
89 |
$24K |
| 85045 |
|
4,559 |
4,152 |
$22K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,468 |
1,409 |
$22K |
| 84702 |
|
1,642 |
1,464 |
$20K |
| 87481 |
|
567 |
542 |
$19K |
| 87150 |
|
740 |
702 |
$18K |
| J1454 |
Injection, fosnetupitant 235 mg and palonosetron 0.25 mg |
51 |
28 |
$15K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
997 |
951 |
$15K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
240 |
234 |
$13K |
| 87081 |
|
1,311 |
1,224 |
$12K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,058 |
1,960 |
$12K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
367 |
360 |
$12K |
| 86803 |
|
593 |
550 |
$12K |
| 74022 |
|
514 |
495 |
$12K |
| 96367 |
|
574 |
337 |
$11K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
123 |
114 |
$11K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
480 |
452 |
$11K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
72 |
50 |
$10K |
| 83605 |
|
836 |
794 |
$10K |
| 86300 |
|
921 |
687 |
$10K |
| 85027 |
|
1,848 |
1,737 |
$10K |
| J1453 |
Injection, fosaprepitant, 1 mg |
51 |
38 |
$9K |
| 83880 |
|
333 |
319 |
$9K |
| 86762 |
|
420 |
393 |
$7K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
5,462 |
5,238 |
$7K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
313 |
280 |
$6K |
| 76801 |
|
201 |
194 |
$6K |
| 87340 |
|
409 |
384 |
$5K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
600 |
559 |
$5K |
| 83020 |
|
252 |
238 |
$5K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,814 |
2,700 |
$5K |
| 96417 |
|
103 |
63 |
$5K |
| 84439 |
|
442 |
404 |
$4K |
| 86850 |
|
651 |
607 |
$4K |
| 85610 |
|
827 |
793 |
$4K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,122 |
1,042 |
$3K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
3,491 |
2,945 |
$3K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
53 |
52 |
$3K |
| 86900 |
|
943 |
884 |
$3K |
| 86140 |
|
1,573 |
1,111 |
$3K |
| 86901 |
|
943 |
884 |
$3K |
| 82378 |
|
131 |
77 |
$3K |
| 97597 |
|
148 |
114 |
$3K |
| 80076 |
|
322 |
311 |
$2K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
15 |
12 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
3,571 |
2,064 |
$2K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
24 |
24 |
$2K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
28 |
26 |
$2K |
| 82105 |
|
78 |
78 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
5,089 |
4,760 |
$2K |
| 82677 |
|
66 |
66 |
$2K |
| 86701 |
|
153 |
145 |
$1K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
81 |
77 |
$1K |
| 87186 |
|
120 |
118 |
$1K |
| 86336 |
|
66 |
66 |
$1K |
| 83516 |
|
19 |
19 |
$1K |
| 80177 |
|
93 |
87 |
$1K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
33 |
28 |
$1K |
| 86235 |
|
15 |
14 |
$1K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
42 |
24 |
$972.00 |
| 85652 |
|
249 |
241 |
$901.50 |
| 82248 |
|
128 |
128 |
$842.15 |
| 76830 |
Ultrasound, transvaginal |
25 |
25 |
$834.12 |
| 87040 |
|
69 |
67 |
$818.91 |
| 73564 |
|
43 |
40 |
$768.03 |
| 36415 |
Collection of venous blood by venipuncture |
7,178 |
5,440 |
$656.35 |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
15 |
14 |
$620.40 |
| 76770 |
|
13 |
12 |
$619.85 |
| 86160 |
|
15 |
14 |
$607.36 |
| 82947 |
|
117 |
107 |
$531.10 |
| 82570 |
|
54 |
54 |
$452.37 |
| 82565 |
|
118 |
116 |
$436.80 |
| 87807 |
|
30 |
30 |
$370.50 |
| 82043 |
|
54 |
54 |
$340.17 |
| 86695 |
|
17 |
17 |
$330.48 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
975 |
545 |
$328.47 |
| 96415 |
|
18 |
12 |
$300.00 |
| 86225 |
|
15 |
14 |
$288.60 |
| 73630 |
|
13 |
12 |
$260.13 |
| 86696 |
|
17 |
17 |
$255.00 |
| 86038 |
|
13 |
12 |
$244.20 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
25 |
24 |
$189.40 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
25 |
24 |
$189.40 |
| 96402 |
|
14 |
12 |
$184.00 |
| 73030 |
|
12 |
12 |
$167.28 |
| 85379 |
|
17 |
16 |
$157.22 |
| 82550 |
|
14 |
13 |
$152.04 |
| 74018 |
|
14 |
14 |
$147.42 |
| 87210 |
|
25 |
25 |
$145.20 |
| 86430 |
|
14 |
13 |
$127.80 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
27 |
25 |
$41.05 |
| 85730 |
|
16 |
14 |
$32.12 |
| J7510 |
Prednisolone oral, per 5 mg |
105 |
97 |
$0.00 |
| 11721 |
|
80 |
76 |
$0.00 |
| 81513 |
|
568 |
518 |
$0.00 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
12 |
12 |
$0.00 |
| 87563 |
|
58 |
52 |
$0.00 |
| 29581 |
|
1,245 |
441 |
$0.00 |
| 80320 |
|
356 |
344 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
37 |
37 |
$0.00 |
| 82962 |
|
74 |
69 |
$0.00 |
| G0475 |
Hiv antigen/antibody, combination assay, screening |
285 |
236 |
$0.00 |
| 83550 |
|
32 |
24 |
$0.00 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
27 |
25 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
13 |
12 |
$0.00 |